Literature DB >> 21197701

Cancer: RANKL inhibition—a new weapon against breast cancer?

Linda Koch.   

Abstract

Entities:  

Year:  2011        PMID： 21197701     DOI： 10.1038/nrendo.2010.202

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  2 in total

1.  Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer.

Authors:  Daniel Schramek; Andreas Leibbrandt; Verena Sigl; Lukas Kenner; John A Pospisilik; Heather J Lee; Reiko Hanada; Purna A Joshi; Antonios Aliprantis; Laurie Glimcher; Manolis Pasparakis; Rama Khokha; Christopher J Ormandy; Martin Widschwendter; Georg Schett; Josef M Penninger
Journal:  Nature       Date:  2010-09-29       Impact factor: 49.962

2.  RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis.

Authors:  Eva Gonzalez-Suarez; Allison P Jacob; Jon Jones; Robert Miller; Martine P Roudier-Meyer; Ryan Erwert; Jan Pinkas; Dan Branstetter; William C Dougall
Journal:  Nature       Date:  2010-09-29       Impact factor: 49.962
  2 in total
  4 in total

1.  Circulating Receptor Activator of Nuclear Factor-κB (RANK), RANK ligand (RANKL), and Mammographic Density in Premenopausal Women.

Authors:  Adetunji T Toriola; Catherine M Appleton; Xiaoyu Zong; Jingqin Luo; Katherine Weilbaecher; Rulla M Tamimi; Graham A Colditz
Journal:  Cancer Prev Res (Phila)       Date:  2018-10-23

Review 2.  Advanced new strategies for metastatic cancer treatment by therapeutic stem cells and oncolytic virotherapy.

Authors:  Geon-Tae Park; Kyung-Chul Choi
Journal:  Oncotarget       Date:  2016-09-06

3.  A Novel Multi-Target Small Molecule, LCC-09, Inhibits Stemness and Therapy-Resistant Phenotypes of Glioblastoma Cells by Increasing miR-34a and Deregulating the DRD4/Akt/mTOR Signaling Axis.

Authors:  Ya-Ting Wen; Alexander Th Wu; Oluwaseun Adebayo Bamodu; Li Wei; Chien-Min Lin; Yun Yen; Tsu-Yi Chao; Debabrata Mukhopadhyay; Michael Hsiao; Hsu-Shan Huang
Journal:  Cancers (Basel)       Date:  2019-09-26       Impact factor: 6.639

4.  Changes in adiposity over the life course and gene expression in postmenopausal women.

Authors:  Yunan Han; Graham A Colditz; Adetunji T Toriola
Journal:  Cancer Med       Date:  2022-03-19       Impact factor: 4.711
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.